Cancer Biomarker Market is expected to grow at a CAGR of 12% by 2026- An exclusive market research report by Lucintel

Cancer Biomarker Market is expected to grow at a CAGR of 12% by 2026- An exclusive market research report by Lucintel
Trends and Forecast for the Global Cancer Biomarker Market
Trends, opportunities and forecast in cancer biomarker market to 2024 by profiling technology (omics, imaging technologies, immunoassays, cytogenetics, and bioinformatics), biomolecules type (protein biomarker, genetic biomarker, and other cancer biomarkers (cell, viral, and carbohydrate biomarkers), cancer type (breast cancer, lung cancer, colorectal cancer, prostate cancer, thyroid cancer, kidney cancer, other cancers (multiple myeloma, cervical, central nervous system cancer,

Lucintel’s latest market report analyzed that cancer biomarker provides attractive opportunities in the diagnostics, research, prognostics, and risk assessment. The cancer biomarker market is expected to grow with a CAGR of 12%. In this market, breast cancer is the largest segment by cancer type, whereas omics are largest by profiling technology.   

Download Brochure of this report by clicking on https://www.lucintel.com/cancer-biomarker-market.aspx    

Based on cancer type, the cancer biomarker market is segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, thyroid cancer, kidney cancer, other cancers (multiple myeloma, cervical, central nervous system cancer, gastric, liver, pancreatic, oral cavity and pharynx, stomach, and ovarian cancer). The breast cancer segment is accounted for the largest share of the market in 2020 due to the high prevalence of breast cancer, increased awareness about breast cancer diagnosis, and increasing research focus on breast cancer.

Browse in-depth TOC on “Cancer Biomarker Market”

XX – Tables

XX – Figures

150 – Pages

The cancer biomarker market is marked by the presence of several big and small players. Some of the prominent players offering cancer biomarker include Thermo Fisher Scientific, Roche Diagnostics, Qiagen N.V., Illumina, Agilent Technologies, Biomérieux, Merck & Co., Abbott Laboratories, Becton Dickinson, and Quest Diagnostics.  

 

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link [email protected].

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Media Contact
Company Name: Lucintel
Contact Person: Brandon Fitzgerald
Email: Send Email
Phone: 303.775.0751
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/


Posted

in

by

Tags: